MARKET

ETON

ETON

Eton Pharmaceuticals
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.25
+0.22
+3.65%
Opening 12:34 12/10 EST
OPEN
6.10
PREV CLOSE
6.03
HIGH
6.29
LOW
6.05
VOLUME
94.39K
TURNOVER
--
52 WEEK HIGH
10.20
52 WEEK LOW
5.13
MARKET CAP
101.99M
P/E (TTM)
-2.6433
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ETON and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ETON News

  • Eton Pharmaceuticals Announces Commercial Availability of Biorphen® (phenylephrine HCI) Injection
  • GlobeNewswire.12/02 12:30
  • The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Arrowhead Earnings And More
  • Benzinga.11/24 21:20
  • Eton Pharmaceuticals EPS misses by $0.03
  • seekingalpha.11/15 02:03
  • Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.11/15 02:02

More

Industry

Biotechnology & Medical Research
+0.71%
Pharmaceuticals & Medical Research
+0.71%

Hot Stocks

Name
Price
%Change

About ETON

Eton Pharmaceuticals, Inc. is a is a specialty pharmaceutical company, which is focused on developing and commercializing pharmaceutical products. It products include EM-100, ET-103, CT-100, DS-300, DS-200, and DS-100. The Company focuses on product candidates that are liquid in formulation, including injections, oral liquids and ophthalmics. EM-100 is an ophthalmic product with a preservative-free formulation of the active ingredient ketotifen, and is indicated for the treatment of allergic conjunctivitis. ET-103 is an oral liquid formulation of levothyroxine, which is widely used in tablet and capsule form, and is indicated for the treatment of hypothyroidism. CT-100 is our patent-pending synthetic corticotropin therapeutic candidate that mimics the amino acid chain of injectable product H.P. Acthar Gel. DS-300 is a patent-pending injectable product candidate indicated to treat nutritional deficiencies. DS-200 is an injectable product candidate indicated to treat pain management.
More

Webull offers Eton Pharmaceuticals Inc (ETON) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.